Quantification of antiangiogenic treatment effects on tissue heterogeneity in glioma tumour xenograft model using a combination of DCE-MRI and 3D-ultramicroscopy.

作者: Marco Dominietto , Michael Dobosz , Sandra Bürgi , Anja Renner , Gudrun Zahlmann

DOI: 10.1007/S00330-016-4629-3

关键词:

摘要: Objectives This study aimed at assessing the effects of an anti-angiogenic treatment, which neutralises vascular endothelial growth factor (VEGF), on tumour heterogeneity.

参考文章(40)
Rangaraj M. Rangayyan, Biomedical image analysis ,(2004)
Louis M. Sherwood, Edith E. Parris, Judah Folkman, Tumor Angiogenesis: Therapeutic Implications New England Journal of Medicine. ,vol. 285, pp. 1182- 1186 ,(1971) , 10.1056/NEJM197111182852108
Philippe L. Bedard, Aaron R. Hansen, Mark J. Ratain, Lillian L. Siu, Tumour heterogeneity in the clinic Nature. ,vol. 501, pp. 355- 364 ,(2013) , 10.1038/NATURE12627
Yasushi Soda, Chad Myskiw, Amy Rommel, Inder M. Verma, Mechanisms of Neovascularization and Resistance to Anti-angiogenic Therapies in Glioblastoma Multiforme Journal of Molecular Medicine. ,vol. 91, pp. 439- 448 ,(2013) , 10.1007/S00109-013-1019-Z
Elizabeth R. Gerstner, Tracy T. Batchelor, Antiangiogenic therapy for glioblastoma. Cancer Journal. ,vol. 18, pp. 45- 50 ,(2012) , 10.1097/PPO.0B013E3182431C6F
Richard C Curry, Saurabh Dahiya, Vyshak Alva Venur, Jeffrey J Raizer, Manmeet S Ahluwalia, Bevacizumab in high-grade gliomas: past, present, and future. Expert Review of Anticancer Therapy. ,vol. 15, pp. 387- 397 ,(2015) , 10.1586/14737140.2015.1028376